Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-17-019287

Senior Vice President and CFO gave up 6,996 shares (to pay taxes)

  • Senior Vice President and CFO acquired 7,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

STAAB THOMAS R II · Senior Vice President and CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-05-22 Exercise or conversion : show line 1 in the form +7,750 $4.73 $36,658 149,210 D
2017-05-22 Shares withheld for taxes : show line 2 in the form −6,996 $5.24 $36,659 142,214 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-05-22 Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) −7,750 $4.73 2022-03-01 7,750 4,000 D
Loading xslF345X03/form4.xml…